Skip Nav Destination
A molecular roadmap for midostaurin in mastocytosis
Free
Effect of a near-universal hospitalization-based prophylaxis regimen on annual number of venous thromboembolism events in the US
Free
How I treat chronic myelomonocytic leukemia
Free
Response and progression on midostaurin in advanced systemic mastocytosis: KIT D816V and other molecular markers
Free
Functional evidence for derivation of systemic histiocytic neoplasms from hematopoietic stem/progenitor cells
Free
The effect of variation in donor platelet function on transfusion outcome: a semirandomized controlled trial
Free
PD-1 blockade for relapsed lymphoma post–allogeneic hematopoietic cell transplant: high response rate but frequent GVHD
Free
Issue Archive
July 13 2017
In this Issue
Table of Contents
INSIDE BLOOD COMMENTARIES
INSIDE BLOOD COMMENTARY
A molecular roadmap for midostaurin in mastocytosis
Free
Clinical Trials & Observations
PLENARY PAPER
THROMBOSIS AND HEMOSTASIS
Effect of a near-universal hospitalization-based prophylaxis regimen on annual number of venous thromboembolism events in the US
Free
Clinical Trials & Observations
PERSPECTIVE
HOW I TREAT
How I treat chronic myelomonocytic leukemia
Free
Clinical Trials & Observations
CLINICAL TRIALS AND OBSERVATIONS
Response and progression on midostaurin in advanced systemic mastocytosis: KIT D816V and other molecular markers
Free
Clinical Trials & Observations
Mohamad Jawhar,Juliana Schwaab,Nicole Naumann,Hans-Peter Horny,Karl Sotlar,Torsten Haferlach,Georgia Metzgeroth,Alice Fabarius,Peter Valent,Wolf-Karsten Hofmann,Nicholas C. P. Cross,Manja Meggendorfer,Andreas Reiter
IMMUNOBIOLOGY
T cells lacking HDAC11 have increased effector functions and mediate enhanced alloreactivity in a murine model Free
David M. Woods,Karrune V. Woan,Fengdong Cheng,Andressa L. Sodré,Dapeng Wang,Yongxia Wu,Zi Wang,Jie Chen,John Powers,Javier Pinilla-Ibarz,Yu Yu,Ya Zhang,Xuefeng Wu,Xiaoyan Zheng,Jeffrey Weber,Wayne W. Hancock,Edward Seto,Alejandro Villagra,Xue-Zhong Yu,Eduardo M. Sotomayor
LYMPHOID NEOPLASIA
USP7 inhibition alters homologous recombination repair and targets CLL cells independently of ATM/p53 functional status Free
Angelo Agathanggelou,Edward Smith,Nicholas J. Davies,Marwan Kwok,Anastasia Zlatanou,Ceri E. Oldreive,Jingwen Mao,David Da Costa,Sina Yadollahi,Tracey Perry,Pamela Kearns,Anna Skowronska,Elliot Yates,Helen Parry,Peter Hillmen,Celine Reverdy,Remi Delansorne,Shankara Paneesha,Guy Pratt,Paul Moss,A. Malcolm R. Taylor,Grant S. Stewart,Tatjana Stankovic
MYELOID NEOPLASIA
Hematopoietic origin of Langerhans cell histiocytosis and Erdheim-Chester disease in adults Free
Paul Milne,Venetia Bigley,Chris M. Bacon,Antoine Néel,Naomi McGovern,Simon Bomken,Muzlifah Haniffa,Eli L. Diamond,Benjamin H. Durham,Johannes Visser,David Hunt,Harsha Gunawardena,Mac Macheta,Kenneth L. McClain,Carl Allen,Omar Abdel-Wahab,Matthew Collin
Functional evidence for derivation of systemic histiocytic neoplasms from hematopoietic stem/progenitor cells
Free
Brief Report
Benjamin H. Durham,Damien Roos-Weil,Claude Baillou,Fleur Cohen-Aubart,Akihide Yoshimi,Makoto Miyara,Matthias Papo,Zofia Hélias-Rodzewicz,Nathalie Terrones,Neval Ozkaya,Ahmet Dogan,Raajit Rampal,Fanny Urbain,Lucie Le Fèvre,Eli L. Diamond,Christopher Y. Park,Thomas Papo,Frédéric Charlotte,Guy Gorochov,Valérie Taly,Olivier A. Bernard,Zahir Amoura,Omar Abdel-Wahab,François M. Lemoine,Julien Haroche,Jean-François Emile
PHAGOCYTES, GRANULOCYTES, AND MYELOPOIESIS
PLATELETS AND THROMBOPOIESIS
RED CELLS, IRON, AND ERYTHROPOIESIS
TRANSFUSION MEDICINE
The effect of variation in donor platelet function on transfusion outcome: a semirandomized controlled trial
Free
Clinical Trials & Observations
Anne M. Kelly,Stephen F. Garner,Theodora Foukaneli,Thomas R. Godec,Nina Herbert,Brennan C. Kahan,Alison Deary,Lekha Bakrania,Charlotte Llewelyn,Willem H. Ouwehand,Lorna M. Williamson,Rebecca A. Cardigan
TRANSPLANTATION
PD-1 blockade for relapsed lymphoma post–allogeneic hematopoietic cell transplant: high response rate but frequent GVHD
Free
Clinical Trials & Observations
Bradley M. Haverkos,Diana Abbott,Mehdi Hamadani,Philippe Armand,Mary E. Flowers,Reid Merryman,Manali Kamdar,Abraham Sebastian Kanate,Ayman Saad,Amitkumar Mehta,Siddhartha Ganguly,Timothy S. Fenske,Parameswaran Hari,Robert Lowsky,Leslie Andritsos,Madan Jagasia,Asad Bashey,Stacey Brown,Veronika Bachanova,Deborah Stephens,Shin Mineishi,Ryotaro Nakamura,Yi-Bin Chen,Bruce R. Blazar,Jonathan Gutman,Steven M. Devine
BLOOD WORK
ERRATA
-
Cover Image
Cover Image
Human megakaryocyte with factor V loaded into its α-granules in green. Staining is as follows: magenta, CD42b (megakaryocyte marker); red, von Willebrand factor (α-granule marker); blue, DAPI (4′,6-diamidino-2-phenylindole) nuclear staining. See the article by Sim et al on page 192.
- PDF Icon Front MatterFront Matter
- PDF Icon Table of ContentsTable of Contents
- PDF Icon Back MatterBack Matter
- PDF Icon Editorial BoardEditorial Board
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals